SCHEMBL30615288

CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](N)C(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@@H](C)CC)C(C)C

nearest known ligand 0.68

Predicted protein targets (top 9)

	gene	UniProt	supporting neighbours	confidence
▸	CXCR4	P61073	7/20	0.68

▸	NPY2R	P49146	8/20	0.68

▸	NPY4R	P50391	8/20	0.68

▸	NPY5R	Q15761	8/20	0.68

▸	NPY1R	P25929	6/20	0.68

▸	IL23R	Q5VWK5	1/20	0.63

▸	GCGR	P47871	1/20	0.58

▸	GIPR	P48546	1/20	0.58

▸	GLP1R	P43220	1/20	0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL31457379	0.94	NPY2R (0.69)	CXCR4NPY2RNPY4RNPY5RNPY1R
SCHEMBL29410243	0.90	CXCR4 (0.72)	CXCR4NPY2RNPY4RNPY5RNPY1R
SCHEMBL29989757	0.90	NPY2R (0.67)	CXCR4NPY2RNPY4RNPY5RNPY1R
SCHEMBL31182504	0.89	NPY2R (0.73)	CXCR4NPY2RNPY4RNPY5RNPY1R
SCHEMBL31154425	0.89	CXCR4 (0.65)	CXCR4NPY2RNPY4RNPY5RNPY1R
SCHEMBL30607498	0.89	NPY2R (0.70)	CXCR4NPY2RNPY4RNPY5RNPY1R
SCHEMBL29352195	0.89	NPY2R (0.70)	CXCR4NPY2RNPY4RNPY5RNPY1R
SCHEMBL30578742	0.89	NPY2R (0.77)	CXCR4NPY2RNPY4RNPY5RNPY1R
SCHEMBL31182564	0.89	NPY1R (0.70)	CXCR4NPY2RNPY4RNPY5RNPY1R
SCHEMBL31182589	0.88	NPY1R (0.68)	CXCR4NPY2RNPY4RNPY5RNPY1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
EP-4531886-A1	PEPTIDES AND METHODS FOR USE IN TREATING PAIN	Tafalgie Therapeutics (FR)	2025-04-09	—	—	EP	disclosed
WO-2023227731-A1	PEPTIDES AND METHODS FOR USE IN TREATING PAIN	TAFALGIE THERAPEUTICS (FR)	2023-11-30	—	—	WO	disclosed